|
Dr. Bondaryk joins us from Proteome Systems, Inc. where he was Executive Vice President, General Manager and Business Development US, managing the US division of the Sydney, Australia-based biotechnology company developing small-molecule enzyme mimetics as therapeutics for a range of indications.
Previously, Bob served as Vice President, Life Science and Drug Discovery at Fisher Scientific, LLC.; Vice President, Corporate Development at IGP, Inc.; Vice President of Corporate Development and Group Coordinator, New Venture Development at Pharm-Eco Laboratories; Co-founder and President of Medtech Capital, Inc.; Vice-President, Boston Capital Group; and Senior Biotechnology Consultant at Arthur D. Little, Inc. He also served on the Board of Directors of Union Biometrica, and currently serves on the Corporation of Boston Biomedical Research Institute.
Bob graduated from Bowdoin College with a Bachelor of Arts degree in Biology and Psychology. He obtained his Ph.D. in Biochemistry from Harvard University. | 